Fibrogen Inc. sell Bank of America Co.
Start price
08.08.23
/
50%
€1.55
Target price
08.08.24
€1.83
Performance (%)
-38.97%
Price
25.04.24
€0.95
Summary
This prediction is currently active. Massive losses of -38.97% have been the result for the SELL prediction by Bank_of_America_Co_. This prediction currently runs until 08.08.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fibrogen Inc. | -11.257% | -11.257% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fibrogen Inc. diskutieren
FibroGen, Inc. (NASDAQ: FGEN) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $2.00 price target on the stock, down previously from $4.00.
Ratings data for FGEN provided by MarketBeat